# A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary

> **NCT01455181** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 24 (actual)

## Conditions studied

- Hypoparathyroidism

## Interventions

- **DRUG:** NPSP558

## Key facts

- **NCT ID:** NCT01455181
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-19
- **Primary completion:** 2012-04-26
- **Final completion:** 2012-04-26
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455181, "A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01455181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*